Zhang Q, Liu Y, Jiang L, Yang D
Pharm Biol. 2025; 63(1):110-117.
PMID: 39902793
PMC: 11795767.
DOI: 10.1080/13880209.2025.2459247.
Zhang P, Lu R
Adv Exp Med Biol. 2024; 1459:379-403.
PMID: 39017853
DOI: 10.1007/978-3-031-62731-6_17.
Jun J, Kim J, Palomera L, Jo D
Arch Pharm Res. 2023; 47(1):20-39.
PMID: 38151648
DOI: 10.1007/s12272-023-01482-x.
Helms R, Marin-Gonzalez A, Patel C, Sun I, Wen J, Leone R
J Immunol. 2023; 211(12):1767-1782.
PMID: 37947442
PMC: 10842463.
DOI: 10.4049/jimmunol.2300248.
Agosto L, Mallory M, Ferretti M, Blake D, Krick K, Gazzara M
Cell Rep. 2023; 42(3):112273.
PMID: 36933216
PMC: 10113009.
DOI: 10.1016/j.celrep.2023.112273.
Role of Histone Deacetylases in T-Cell Development and Function.
Pieniawska M, Izykowska K
Int J Mol Sci. 2022; 23(14).
PMID: 35887172
PMC: 9320103.
DOI: 10.3390/ijms23147828.
Histone deacetylase 7: a signalling hub controlling development, inflammation, metabolism and disease.
Wang Y, Abrol R, Mak J, Das Gupta K, Ramnath D, Karunakaran D
FEBS J. 2022; 290(11):2805-2832.
PMID: 35303381
PMC: 10952174.
DOI: 10.1111/febs.16437.
KLF2 up-regulates IRF4/HDAC7 to protect neonatal rats from hypoxic-ischemic brain damage.
Wu F, Li C
Cell Death Discov. 2022; 8(1):41.
PMID: 35091544
PMC: 8799701.
DOI: 10.1038/s41420-022-00813-z.
Acetylation in Tumor Immune Evasion Regulation.
Lu J, He X, Zhang L, Zhang R, Li W
Front Pharmacol. 2021; 12:771588.
PMID: 34880761
PMC: 8645962.
DOI: 10.3389/fphar.2021.771588.
Salt inducible kinases 2 and 3 are required for thymic T cell development.
Nefla M, Darling N, van Gijsel Bonnello M, Cohen P, Arthur J
Sci Rep. 2021; 11(1):21550.
PMID: 34732767
PMC: 8566462.
DOI: 10.1038/s41598-021-00986-0.
Insights Into the Function and Clinical Application of HDAC5 in Cancer Management.
Yang J, Gong C, Ke Q, Fang Z, Chen X, Ye M
Front Oncol. 2021; 11:661620.
PMID: 34178647
PMC: 8222663.
DOI: 10.3389/fonc.2021.661620.
Role of the Orphan Nuclear Receptor NR4A Family in T-Cell Biology.
Odagiu L, May J, Boulet S, Baldwin T, Labrecque N
Front Endocrinol (Lausanne). 2021; 11:624122.
PMID: 33597928
PMC: 7883379.
DOI: 10.3389/fendo.2020.624122.
Lysine acetylation of cytoskeletal proteins: Emergence of an actin code.
A M, Latario C, Pickrell L, Higgs H
J Cell Biol. 2020; 219(12).
PMID: 33044556
PMC: 7555357.
DOI: 10.1083/jcb.202006151.
Recent Update of HDAC Inhibitors in Lymphoma.
Chen I, Sethy B, Liou J
Front Cell Dev Biol. 2020; 8:576391.
PMID: 33015069
PMC: 7494784.
DOI: 10.3389/fcell.2020.576391.
A small molecular compound CC1007 induces cross-lineage differentiation by inhibiting HDAC7 expression and HDAC7/MEF2C interaction in BCR-ABL1 pre-B-ALL.
Wang Z, Zhang Y, Zhu S, Peng H, Chen Y, Cheng Z
Cell Death Dis. 2020; 11(9):738.
PMID: 32913188
PMC: 7483467.
DOI: 10.1038/s41419-020-02949-1.
MEF2D sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity.
Di Giorgio E, Wang L, Xiong Y, Akimova T, Christensen L, Han R
J Clin Invest. 2020; 130(12):6242-6260.
PMID: 32790649
PMC: 7685736.
DOI: 10.1172/JCI135486.
mTOR and other effector kinase signals that impact T cell function and activity.
Myers D, Wheeler B, Roose J
Immunol Rev. 2019; 291(1):134-153.
PMID: 31402496
PMC: 6697425.
DOI: 10.1111/imr.12796.
Promoter conservation in HDACs points to functional implications.
Boltz T, Khuri S, Wuchty S
BMC Genomics. 2019; 20(1):613.
PMID: 31351464
PMC: 6660948.
DOI: 10.1186/s12864-019-5973-x.
Harnessing the HDAC-histone deacetylase enzymes, inhibitors and how these can be utilised in tissue engineering.
Lawlor L, Yang X
Int J Oral Sci. 2019; 11(2):20.
PMID: 31201303
PMC: 6572769.
DOI: 10.1038/s41368-019-0053-2.
Restoring T Cell Tolerance, Exploring the Potential of Histone Deacetylase Inhibitors for the Treatment of Juvenile Idiopathic Arthritis.
Nijhuis L, Peeters J, Vastert S, van Loosdregt J
Front Immunol. 2019; 10:151.
PMID: 30792714
PMC: 6374297.
DOI: 10.3389/fimmu.2019.00151.